These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 30639387)

  • 1. Reassembly of native components with donepezil to execute dual-missions in Alzheimer's disease therapy.
    Zhang H; Zhao Y; Yu M; Zhao Z; Liu P; Cheng H; Ji Y; Jin Y; Sun B; Zhou J; Ding Y
    J Control Release; 2019 Feb; 296():14-28. PubMed ID: 30639387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GM1-Modified Lipoprotein-like Nanoparticle: Multifunctional Nanoplatform for the Combination Therapy of Alzheimer's Disease.
    Huang M; Hu M; Song Q; Song H; Huang J; Gu X; Wang X; Chen J; Kang T; Feng X; Jiang D; Zheng G; Chen H; Gao X
    ACS Nano; 2015 Nov; 9(11):10801-16. PubMed ID: 26440073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein-based nanoparticles rescue the memory loss of mice with Alzheimer's disease by accelerating the clearance of amyloid-beta.
    Song Q; Huang M; Yao L; Wang X; Gu X; Chen J; Chen J; Huang J; Hu Q; Kang T; Rong Z; Qi H; Zheng G; Chen H; Gao X
    ACS Nano; 2014 Mar; 8(3):2345-59. PubMed ID: 24527692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconstituted high-density lipoproteins acutely reduce soluble brain Aβ levels in symptomatic APP/PS1 mice.
    Robert J; Stukas S; Button E; Cheng WH; Lee M; Fan J; Wilkinson A; Kulic I; Wright SD; Wellington CL
    Biochim Biophys Acta; 2016 May; 1862(5):1027-36. PubMed ID: 26454209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donepezil attenuates Aβ-associated mitochondrial dysfunction and reduces mitochondrial Aβ accumulation in vivo and in vitro.
    Ye CY; Lei Y; Tang XC; Zhang HY
    Neuropharmacology; 2015 Aug; 95():29-36. PubMed ID: 25744714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomimetic ApoE-Reconstituted High Density Lipoprotein Nanocarrier for Blood-Brain Barrier Penetration and Amyloid Beta-Targeting Drug Delivery.
    Song Q; Song H; Xu J; Huang J; Hu M; Gu X; Chen J; Zheng G; Chen H; Gao X
    Mol Pharm; 2016 Nov; 13(11):3976-3987. PubMed ID: 27700119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donepezil loaded PLGA-b-PEG nanoparticles: their ability to induce destabilization of amyloid fibrils and to cross blood brain barrier in vitro.
    Baysal I; Ucar G; Gultekinoglu M; Ulubayram K; Yabanoglu-Ciftci S
    J Neural Transm (Vienna); 2017 Jan; 124(1):33-45. PubMed ID: 26911385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oleocanthal-rich extra-virgin olive oil enhances donepezil effect by reducing amyloid-β load and related toxicity in a mouse model of Alzheimer's disease.
    Batarseh YS; Kaddoumi A
    J Nutr Biochem; 2018 May; 55():113-123. PubMed ID: 29413486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
    Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
    Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development of advanced structural framework as multi-target-directed ligands for the treatment of Alzheimer's disease.
    Sang Z; Wang K; Shi J; Liu W; Cheng X; Zhu G; Wang Y; Zhao Y; Qiao Z; Wu A; Tan Z
    Eur J Med Chem; 2020 Apr; 192():112180. PubMed ID: 32131034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors.
    Lan JS; Zhang T; Liu Y; Yang J; Xie SS; Liu J; Miao ZY; Ding Y
    Eur J Med Chem; 2017 Jun; 133():184-196. PubMed ID: 28388521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
    Shackleton B; Crawford F; Bachmeier C
    Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donepezil provides neuroprotective effects against brain injury and Alzheimer's pathology under conditions of cardiac ischemia/reperfusion injury.
    Ongnok B; Khuanjing T; Chunchai T; Kerdphoo S; Jaiwongkam T; Chattipakorn N; Chattipakorn SC
    Biochim Biophys Acta Mol Basis Dis; 2021 Jan; 1867(1):165975. PubMed ID: 32956775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and Functional Impairments of Reconstituted High-Density Lipoprotein by Incorporation of Recombinant β-Amyloid42.
    Cho KH
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral administration of human recombinant ApoJ/clusterin modulates brain beta-amyloid levels in APP23 mice.
    de Retana SF; Marazuela P; Solé M; Colell G; Bonaterra A; Sánchez-Quesada JL; Montaner J; Maspoch D; Cano-Sarabia M; Hernández-Guillamon M
    Alzheimers Res Ther; 2019 May; 11(1):42. PubMed ID: 31077261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of donepezil against Abeta(1-40) neurotoxicity in rat septal neurons.
    Kimura M; Akasofu S; Ogura H; Sawada K
    Brain Res; 2005 Jun; 1047(1):72-84. PubMed ID: 15893738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of ApoJ-reconstituted high-density lipoprotein (rHDL) nanodisc for the potential treatment of cerebral β-amyloidosis.
    Fernández-de-Retana S; Cano-Sarabia M; Marazuela P; Sánchez-Quesada JL; Garcia-Leon A; Montañola A; Montaner J; Maspoch D; Hernández-Guillamon M
    Sci Rep; 2017 Nov; 7(1):14637. PubMed ID: 29116115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Systematic Review on Donepezil-based Derivatives as Potential Cholinesterase Inhibitors for Alzheimer's Disease.
    Korabecny J; Spilovska K; Mezeiova E; Benek O; Juza R; Kaping D; Soukup O
    Curr Med Chem; 2019; 26(30):5625-5648. PubMed ID: 29768996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-Related Decline in Brain and Hepatic Clearance of Amyloid-Beta is Rectified by the Cholinesterase Inhibitors Donepezil and Rivastigmine in Rats.
    Mohamed LA; Qosa H; Kaddoumi A
    ACS Chem Neurosci; 2015 May; 6(5):725-36. PubMed ID: 25782004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamics of cholinesterase inhibitors suggests add-on therapy with a low-dose carbamylating inhibitor in patients on long-term treatment with rapidly reversible inhibitors.
    Darreh-Shori T; Hosseini SM; Nordberg A
    J Alzheimers Dis; 2014; 39(2):423-40. PubMed ID: 24217282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.